Frederick Lowery is recorded as CEO and Board Member at Henry Schein Inc (HSIC). Henry Schein Inc reported in an 8-K filed January 12, 2026 that Frederick Lowery was appointed member of the Board of Directors, effective March 2, 2026. Henry Schein Inc reported in an 8-K filed January 12, 2026 that Frederick Lowery was appointed Chief Executive Officer, effective March 2, 2026. The proxy statement of Thermo Fisher Scientific Inc. reports total compensation of $6,575,821 for Frederick Lowery in fiscal 2025, including a base salary of $930,356. Disclosed compensation is on record for 2 fiscal years. Frederick Lowery has spoken on 2 earnings calls across 1 company, most recently for Henry Schein Inc on May 5, 2026. Henry Schein Inc is classified in the Medical Distribution industry within the Healthcare sector. Thermo Fisher Scientific Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Henry Schein Inc includes Andrea Albertini (CEO), Frederick M. Lowery (CEO and Board Member), R. Steven Boggan (CEO) and 7 others.
“In connection with Mr. Lowery’s appointment, the Board expanded the size of the Board from 14 to 15 members and appointed Mr. Lowery to fill the resulting vacancy, in each case, effective as of the Effective Date.”
Henry Schein Inc Form 8-K, filed January 12, 2026
· Read the filing
“On January 10, 2026, the Board of Directors \(the “Board”\) of Henry Schein, Inc. \(the “Company”\) appointed Mr. Frederick Lowery as Chief Executive Officer of the Company, effective March 2, 2026 \(the “Effective Date”\).”
Henry Schein Inc Form 8-K, filed January 12, 2026
· Read the filing
Frederick Lowery on recent calls
“When I just take a step back and think about the positives, you know, the biggest positive to me, and I sort of said it in the script, has been the confirmation that the set of assets that Henry Schein owns, that we own, are incredibly important to customers.”
“Excited to be here today, and I'm looking forward to getting started next week and working with this high-performance team and leading this exceptional company into its next phase.”
